Modulation of angiogenesis by tissue inhibitor of metalloproteinase-4

被引:34
作者
Fernandez, Cecilia A.
Moses, Marsha A. [1 ]
机构
[1] Harvard Univ, Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA
[2] Harvard Univ, Childrens Hosp, Dept Surg, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
关键词
MMP; matrix metalloproteinase; TIMP; tissue inhibitor of metalloproteinase; angiogenesis; endothelial cell;
D O I
10.1016/j.bbrc.2006.04.083
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite the importance of MMP activity in the regulation of angiogenesis, relatively little is known about the role of TIMP-4, the most recently discovered endogenous MMP inhibitor, in modulating neovascularization. It has largely been assumed that all TIMPs are capable of inhibiting angiogenesis in vivo. However, it is now widely appreciated that TIMPs-1, -2, and -3 differ significantly in their ability to modulate angiogenic processes in vitro and angiogenesis in vivo. In order to study the effect of TIMP-4 in controlling angiogenesis, we have cloned and expressed TIMP-4 in a Pichia pastoris expression system, purified it to homogeneity, and tested its ability to regulate angiogenesis in vivo and in vitro. Our studies demonstrate that TIMP-4 is an inhibitor of capillary endothelial cell migration, but not of proliferation or of angiogenesis in vivo. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:523 / 529
页数:7
相关论文
共 35 条
[1]  
AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817
[2]   Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP4) to the COOH-terminal hemopexin-like domain of human gelatinase A - TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2 [J].
Bigg, HF ;
Shi, YE ;
Liu, YLE ;
Steffensen, B ;
Overall, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (24) :15496-15500
[3]  
Bigg HF, 2001, CANCER RES, V61, P3610
[4]   Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA [J].
Çeliker, MY ;
Wang, M ;
Atsidaftos, E ;
Liu, X ;
Liu, YE ;
Jiang, Y ;
Valderrama, E ;
Goldberg, ID ;
Shi, YE .
ONCOGENE, 2001, 20 (32) :4337-4343
[5]   DETERMINATION OF THE NUMBER OF ENDOTHELIAL-CELLS IN CULTURE USING AN ACID-PHOSPHATASE ASSAY [J].
CONNOLLY, DT ;
KNIGHT, MB ;
HARAKAS, NK ;
WITTWER, AJ ;
FEDER, J .
ANALYTICAL BIOCHEMISTRY, 1986, 152 (01) :136-140
[6]   Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model [J].
Fang, JM ;
Shing, Y ;
Wiederschain, D ;
Yan, L ;
Butterfield, C ;
Jackson, G ;
Harper, J ;
Tamvakopoulos, G ;
Moses, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) :3884-3889
[7]   The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients [J].
Fernández, CA ;
Yan, L ;
Lous, G ;
Yang, J ;
Kutok, JL ;
Moses, MA .
CLINICAL CANCER RESEARCH, 2005, 11 (15) :5390-5395
[8]   Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2) -: Loop 6 is a novel angiogenesis inhibitor [J].
Fernández, CA ;
Butterfield, C ;
Jackson, G ;
Moses, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) :40989-40995
[9]  
Green MA, 1996, PROG PHOTOVOLTAICS, V4, P375, DOI 10.1002/(SICI)1099-159X(199609/10)4:5<375::AID-PIP146>3.0.CO
[10]  
2-S